We were commissioned by global pharmaceutical company Mallinckrodt to develop a communications concept for the introduction of a drug against Multiple Sclerosis.
Later, the same medicine would also be used for other indications. In order to make a big impact from the get-go, a strong positioning of the medicine was needed. Product values, proposition, mission, and other basic components for effective communication were examined and optimized, and then we started working with various parties to put a solid marketing and communication strategy on paper.Based on desk research and several C-level interview sessions, we drafted a discussion paper and subsequently developed a presentation on the MS drug.
In our communications, the emphasis was very clearly on transparency and authenticity, not least because every pharmaceutical company, without exception, is confronted with the lack of these values in the sector.The main findings from the discussion paper:
Working with the right propositions is essential, for all possible marketing materials. It is important to assess whether the different target groups have different needs or a different level of knowledge. After developing the propositions, we had a solid basis with which sales and communication could reach their target groups.
Based on the outcome of the strategy sessions, we developed a logo, a corporate identity, a communication style and a digital style.
In this phase we developed a large number of components and carried out multiple activities.
We started with an overarching plan and worked with our Worldcom partners to provide localized versions for each country involved. The components that were developed and localized included:The tools we used in the campaigns included: